Trending Now
Unusual Call Activity that needs immediate attention
Below are some of the most unusual option activity from Friday's action that needs to be monitored for Monday.
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Metaverse Small Caps Poised After Goldman Sachs Points to $8 Trillion...
The metaverse theme has been percolating in the integumentary tissue of the market since Facebook changed its name to Meta Platforms Inc....
MAKE IT MODERN
LATEST REVIEWS
SPY puts are still Wall Street’s favorite
Futures are up a bit this morning but have yo yoed all morning. The SPY is currently sitting at 314.22 in the...
MAKE IT MODERN
PERFORMANCE TRAINING
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) Enters Co-Promotion Partnership Deal For Probuphine Implant With Indegene
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has announced that it has signed a co-promotion partnership agreement with Indegene Inc. The partnership is meant to establish multichannel...
ISW Holdings Inc (OTCMKTS:ISWH) New Telehealth Business Just Got Good News
While telehealth is a powerful revolution according to basically everyone on the planet right now, and one that’s likely to be here and dominant...
Charlotte’s Web Holdings Inc (OTCMKTS:CWBHF) Gets Back on the Map with Change at the...
Charlotte's Web Holdings Inc (OTCMKTS:CWBHF) is a leader in the CBD space based on market penetration over recent years.
Halozyme’s ENHANZE® (HALO) Technology Empowers OCREVUS ZUNOVO™: A New Era in MS Treatment
Subcutaneous Convenience, Uncompromised Efficacy
Halozyme Therapeutics (NASDAQ: HALO), a leader in innovative drug delivery solutions, recently announced a significant...
Moderna (NASDAQ: MRNA) Receives Emergency Use Authorization For Its COVID-19 Vaccine In Adolescents in...
Moderna (NASDAQ: MRNA) has received approval from the Philippines Food and Drug Administration for its coronavirus vaccine for children between 12 and 17 years.
The...






















































